| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3662ce5995dada5ea3d9873552592af0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6844
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 |
| filingDate |
2010-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fceb585c66717518028e634c9cda3a8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_918ba76f7192d06a8dffe6a6f714ac18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b13d65184e13c3989f7c90d15c07bf31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f874b46ccf2ba205793fee9945e27a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82eef70009616f432fba7b3a99c939a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2004a1477bf16c9a200434e9a807ad54 |
| publicationDate |
2012-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120093956-A |
| titleOfInvention |
Quantification of IR-A and IR-Ｂ for Tumor Classification |
| abstract |
Without limitation, the present disclosure relates to compositions and methods for detecting and quantifying expression of insulin receptor isoform A (IR-A) and / or insulin receptor isotype B (IR-B) in tissue samples. . In addition, the present disclosure is a method of diagnosing and classifying based at least in part on detecting and quantifying expression of insulin receptor isotype A (IR-A) and / or insulin receptor isotype B (IR-B) in a tissue sample. It is about. Methods of treating a subject based on this classification belong to further aspects of the present disclosure presented herein. |
| priorityDate |
2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |